跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRAN ETEXILATO SAG 150 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRAN ETEXILATO SAG 150 MG CAPSULAS DURAS EFG
Approved
STANDARD
DABIGATRAN ETEXILATO SAG 150 MG CAPSULAS DURAS EFG
Galenicum Health S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 23, 2024
Approval ID
1ad4ebd5a613b4bf
Company
Galenicum Health S.L.U.
Type
Standard
Approval Details
Approval Id
1ad4ebd5a613b4bf
Drug Cima Aemps Name
DABIGATRAN ETEXILATO SAG 150 MG CAPSULAS DURAS EFG
Register Number
89373
Holder Company Name
Galenicum Health S.L.U.
Marketing Company Name
Galenicum Health S.L.U.
Authorization Date
2024-02-23
Dosage Form
CÁPSULA DURA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Galenicum Health S.L.U.
Active Ingredients
DABIGATRAN ETEXILATO MESILATO
172,95 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 23, 2024
Approval ID
1ad4ebd5a613b4bf
Type
Standard
Back to CIMA-AEMPS Approvals
